πŸ‡ΊπŸ‡Έ FDA
Patent

US 6194388

Immunomodulatory oligonucleotides

expired A61KA61K2039/55561A61K31/70

Quick answer

US patent 6194388 (Immunomodulatory oligonucleotides) held by The United States of America expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America
Grant date
Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/55561, A61K31/70, A61K31/7125, A61K39/39